Heavy metal legend diagnosed with lymphoma

According to information released by a publicist of the band Black Sabbath, guitarist Tommy Iommi has been diagnosed with lymphoma.

The only hint of the gravity of the disease was that it had been found in the early stages. The band, which has been recording the first new album from the original foursome in over three decades in Los Angeles, said they will move operations from LA to England to make things easier on Iommi as he begins unidentified treatment.

Last year, Iommi published his autobiography, "“Iron Man: My Journey Through Heaven and Hell with Black Sabbath." The band had originally scheduled the launch of their world tour to begin in Moscow in late May, but with the diagnosis it is possible that this will be delayed.

The band has asked fans to send "positive vibes" to the legendary guitarist as he considers his treatment options.

Source: New York Daily News

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap